Bookmark and Share

Clarissa J Diamantidis
 

Clarissa J Diamantidis M.D., M.H.S.

Academic Title: Assistant Professor
Primary Appointment: Medicine
cdiamantidis@medicine.umaryland.edu
Location: UMMC, N3W143
Phone: (410) 328-5720
Fax: (410) 328-5685

Personal History:

Dr. Clarissa Jonas Diamantidis, MD, MHS is an Assistant Professor of Medicine in the Division of Nephrology. Dr. Diamantidis received her undergraduate degree at the University of Pennsylvania in Philadelphia, PA, followed by a Master’s of Science degree at New York Medical College in Valhalla, NY. She subsequently received her Medical Degree from New York Medical College and went on to complete her Internal Medicine training at Duke University Medical Center in Durham, NC. She received her Nephrology training at Johns Hopkins Hospital, and completed a Masters of Health Science degree during this time at the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD. Dr. Diamantidis joined the renal epidemiology group at the University of Maryland School of Medicine in 2010, and is an active participant in the Early Renal Insufficiency (ERI) Program at the Baltimore VA and University of Maryland Medical System under the mentorship of Dr. Jeffrey Fink. Dr. Diamantidis is a staff physician at the Baltimore VA Medical Center, and often serves as an attending on the general medicine services, where she enjoys interacting with and educating house staff and medical students. She is also a member of the National Kidney Foundation of Maryland Medical Advisory Board, and has a dedication to promoting kidney disease awareness within the Baltimore community.

Research Interests:

My primary research interests focus on patient awareness in chronic kidney disease (CKD), health disparities in CKD, and promoting patient safety in CKD through the use of novel health information technology (IT) tools. I have been fortunate to collaborate with Dr. Jeffrey Fink on his Safe Kidney Care Cohort study (R01DK08407) which examines the relationship between patient safety and CKD, as well the Chronic Renal Insufficiency Cohort (CRIC) study (U01 DK61022) on which I am a co-investigator, and Dr. Fink’s CRIC-Safety study (R01DK09008) which retrospectively examines the frequency of safety events in the CRIC cohort. I have also been the recipient of a National Kidney Foundation of Maryland Professional Development Award as well as the Baltimore Research and Education Fund pilot study grant.


Publications:

Diamantidis, CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE. “Primary Care-Specialist Collaboration in the Care of Patients with Chronic Kidney Disease.” Clinical Journal of the American Society of Nephrology. 2011 Feb.(6)2):334-43

Seliger SL, Zhang AD, Weir MR, Walker L, Hsu VD, Parsa A, Diamantidis CJ, Fink JC. “Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.” Kidney International. 2011 Aug;80(3)299-94

Diamantidis CJ, Seliger SL, Zhan M, Walker L, Rattinger GB, Hsu VD, Fink JC. “A varying safety profile between blacks and non-blacks with decreased estimated GFR.” American Journal of Kidney Diseases 2012; 60(2):47-53.

Patel K, Diamantidis C, Zhan M, Hsu VD, Walker LD, Gardner J, Weir MR, Fink JC. “Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.” American Journal of Nephrology 2012;36:19-26.

Diamantidis CJ, Zuckerman, M, Fink W, Hu P, Yang S, Fink JC. “Usability of a CKD educational website targeted to patients and their family members.” Clinical Journal of the American Society of Nephrology. 2012 (epub ahead of print).

Diamantidis CJ, Zuckerman MA, Fink W, Aggarwal S, Prakash D, Fink JC. “Usability testing and acceptance of an electronic Medication Inquiry System for CKD patients.” American Journal of Kidney Diseases. November 2012. Epub.